At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 8 enrolled
Drug / intervention
Deucravacitinibdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase IV, Open-label, Single-group, Single-dose Study Evaluating Deucravacitinib Concentrations in the Breast Milk and Plasma of Healthy Lactating Female Participants
In Brief
A Phase 4 clinical trial evaluating Deucravacitinib for Healthy Volunteers. Completed, enrolled 8 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate Deucravacitinib concentrations in the breast milk and plasma of healthy lactating female participants.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteers
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20252026
Enrollment StartJun 2024
First PostedJun 2024
Primary CompletionNov 2024
TodayJul 2026
First PostedJun 26, 2024
Enrollment StartJun 24, 2024
Primary CompletionNov 2, 2024
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 2.0 years ago
Interventions
Deucravacitinibdrug
Specified dose on specified days